| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
British Medical Bulletin 62:113-123 (2002)
© 2002 The British Council
Vaccines against human enteric bacterial pathogens
Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London, UK
The development of vaccines against enteric bacterial pathogens presents a challenge because of the large number of pathogens capable of causing disease and the requirement to induce immunity that is effective in the gut. A new generation of enteric vaccines based either on live or non-living antigens delivered orally or by injection are reaching the clinic in the early phases of evaluation. However, considerable technical barriers have to be overcome before these vaccines reach the general population.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. J Xavier, A. Huett, and J. D Rioux Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis Gut, June 1, 2008; 57(6): 717 - 720. [Full Text] [PDF] |
||||
